January 2025
The global medical affairs outsourcing market size is evaluated at USD 2.08 billion in 2025 and is forecasted to hit around USD 3.89 billion by 2034, growing at a CAGR of 7.18% from 2025 to 2034. The North America market size was accounted at USD 710 million in 2024 and is expanding at a CAGR of 6.64% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
The global medical affairs outsourcing market size accounted for USD 1.95 billion in 2024 and is predicted to increase from USD 2.08 billion in 2025 to approximately USD 3.89 billion by 2034, expanding at a CAGR of 7.18% from 2025 to 2034.
The U.S. medical affairs outsourcing market size was exhibited at USD 580 million in 2024 and is projected to be worth around USD 1,150 million by 2034, growing at a CAGR of 7.05% from 2025 to 2034.
North America region emerged as most dominating market place for the medical affairs outsourcing business in 2024 an estimated to mirror this predominance the period. Reasons such as vigorous FDA supervisors, existence of international life sciences and pharmaceutical giants and availability of talent pool are prospering the growth of the market in this region. The mounting figures of patent expirations along with escalating spending of research and development undertakings are some of the crucial factors persuading the event of the global medical affairs outsourcing market.
As rivalry in the international medical device market exaggerates, the U.S. medical businesses are progressively looking for means to decrease costs in manufacturing, clinical trials, research and development, and other medical services. Numerous Asian nationsbid a lower charge of labor such as China and India and skillful labor force. Merging this with the region’s fast-growing markets and growing mature populations propose encouraging openings for the U.S. medical device corporations outsourcing their affairs to Asia Pacific. For instance, at present elderly population in Japan is around 20% against 12% aged population in the U.S.
Current trends display an upsurge in subcontracting vital functional accomplishments predominantly in medical affairs including medical material, field-based medical teams and medical publications. Outsourcing medical affairs provides corporations cost-effective and flexible solution to address the budding issues and demands faced by the business. The regulatory setting is becoming rough due to amplified association among global regulatory bodies. As an outcome, compensations and drug approval need companies’ medical affairs to gather snowballing amounts of complicated, real-life patient outcomes data to establish product value.
Several countries are progressively intensifying their R&D expenditure that has prompted expansion of innovative products in the market. With the cumulative stringency by the particular regulatory authorities globally, a rising partnership among clinical research organizations, the drug developers and contract manufacturing organizations has been perceived to alleviate risks. As CMOs and CROs assist the corporations into reduce risks, companies are able to emphasis on their fundamental dealings. Hence, escalating research and development activities plus patent expirations are considered to be major growth influencers driving the global medical affairs outsourcing market.
Report Highlights | Details |
Growth Rate from 2025 to 2034 | CAGR of 7.18% |
Market Size in 2025 | USD 2.08 Billion |
Market Size by 2034 | USD 3.89 Billion |
Base Year | 2024 |
Forecast Period | 2025 to 2034 |
Segments Covered | Services, Industry and Region |
Regional Scope | North America, APAC, Europe, Latin America, MEAN, Rest of the World |
Different medical services analyzed in this research report include medical monitoring, medical writing & publishing, medical information, medical science liaisons and others. Out of all these services, medical writing & publishing appeared as most promising segment and garnered maximum revenue share of 33.64% in 2024. Currently, plentiful of the big pharma corporations are subcontracting their clinical data management to specialized medical writing & publishing service suppliers. Demand for professional medical writers is projected to grow considerably due to escalating introduction of assorted pharma products in the market. As a result, augmented need for professional medical writers is projected as the crucial influencers for growth of medical writing & publishing market segment.
The Medical Science Liaisons (MSLs) services segment projected to record fastest developing growth rate during assessment period.These are medical specialists with cutting-edge scientific training and are experts in cooperating intricate medical data to a diversity of stakeholders. The biopharma business sector is concentrating on the core undertakings associated to drug development than non-core actions including medical affairs. In order to decreases pending and profit from professional medical affairs services, biopharmafrims are subcontracting these services to the CROs or contract research organizations. Biotechnology businesses are further continuing at a great pace and are anticipated to offer a resilient competition to mid-size pharma firms during next few years.
Global Medical Affairs Outsourcing Market Revenue, By Services, 2022-2024 (USD Million)
By Services | 2022 | 2023 | 2024 |
Medical Writing & Publishing | 564.37 | 607.61 | 654.62 |
Medical Monitoring | 161.36 | 173.38 | 186.42 |
Medical Science Liaisons | 329.72 | 338.41 | 347.58 |
Medical Information | 443.24 | 471.52 | 501.94 |
Others | 202.52 | 227.90 | 255.35 |
Global medical affairs outsourcing market report assessed different end-use industries making most of these outsourcing services in this research report including biopharmaceutical, pharmaceutical, and medical devices among others.
Among these, pharmaceutical segment dominated the global market by accounting prominent share more than 52.86% of the total revenue generated by market in 2024. This growth is attributed to the growing demand of medical affairs service for the groundwork of drafts of fresh patents due to expiration of different existing patents.
Global Medical Affairs Outsourcing Market Revenue, By Industry, 2022-2024 (USD Million)
By Industry | 2022 | 2023 | 2024 |
Pharmaceutical | 898.33 | 961.40 | 1,029.61 |
Biopharmaceutical | 228.76 | 245.56 | 263.76 |
Medical Devices | 574.11 | 611.87 | 652.55 |
By Services
By Industry
By Region
For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
January 2025
March 2025
August 2024
January 2025